Suppr超能文献

微小RNA-340介导的小眼相关转录因子(MITF)信使核糖核酸的降解受到编码区决定簇结合蛋白(CRD-BP)的抑制。

MicroRNA-340-mediated degradation of microphthalmia-associated transcription factor (MITF) mRNA is inhibited by coding region determinant-binding protein (CRD-BP).

作者信息

Goswami Srikanta, Tarapore Rohinton S, Poenitzsch Strong Ashley M, TeSlaa Jessica J, Grinblat Yevgenya, Setaluri Vijayasaradhi, Spiegelman Vladimir S

机构信息

From the Department of Dermatology and Paul P. Carbone Comprehensive Cancer Center.

From the Department of Dermatology and Paul P. Carbone Comprehensive Cancer Center, the Molecular and Environmental Toxicology Center, and.

出版信息

J Biol Chem. 2015 Jan 2;290(1):384-95. doi: 10.1074/jbc.M114.590158. Epub 2014 Nov 20.

Abstract

Alternative cleavage and polyadenylation generates multiple transcript variants producing mRNA isoforms with different length 3'-UTRs. Alternative cleavage and polyadenylation enables differential post-transcriptional regulation via the availability of different cis-acting elements in 3'-UTRs. Microphthalmia-associated transcription factor (MITF) is a master regulator of melanocyte development and melanogenesis. This central transcription factor is also implicated in melanoma development. Here, we show that melanoma cells favor the expression of MITF mRNA with a shorter 3'-UTR. We also establish that this isoform is regulated by a micro RNA (miRNA/miR), miR-340. miR-340 interacts with two of its target sites on the MITF 3'-UTR, causing mRNA degradation as well as decreased expression and activity of MITF. Conversely, the RNA-binding protein, coding region determinant-binding protein, was shown to be highly expressed in melanoma, directly binds to the 3'-UTR of MITF mRNA, and prevents the binding of miR-340 to its target sites, resulting in the stabilization of MITF transcripts, elevated expression, and transcriptional activity of MITF. This regulatory interplay between RNA-binding protein and miRNA highlights an important mechanism for the regulation of MITF in melanocytes and malignant melanomas.

摘要

可变剪接和多聚腺苷酸化产生多种转录变体,生成具有不同长度3'-UTR的mRNA异构体。可变剪接和多聚腺苷酸化通过3'-UTR中不同顺式作用元件的可用性实现差异转录后调控。小眼畸形相关转录因子(MITF)是黑素细胞发育和黑素生成的主要调节因子。这个核心转录因子也与黑色素瘤的发展有关。在这里,我们表明黑色素瘤细胞倾向于表达具有较短3'-UTR的MITF mRNA。我们还确定这种异构体受微小RNA(miRNA/miR)miR-340调控。miR-340与其在MITF 3'-UTR上的两个靶位点相互作用,导致mRNA降解以及MITF的表达和活性降低。相反,RNA结合蛋白编码区决定簇结合蛋白在黑色素瘤中高度表达,直接与MITF mRNA的3'-UTR结合,并阻止miR-340与其靶位点结合,从而导致MITF转录本的稳定、表达升高以及MITF的转录活性增强。RNA结合蛋白和miRNA之间的这种调节相互作用突出了黑素细胞和恶性黑色素瘤中MITF调节的重要机制。

相似文献

5
MicroRNA-25 functions in regulation of pigmentation by targeting the transcription factor MITF in Alpaca (Lama pacos) skin melanocytes.
Domest Anim Endocrinol. 2010 Apr;38(3):200-9. doi: 10.1016/j.domaniend.2009.10.004. Epub 2009 Nov 25.
6
7
miR-148 regulates Mitf in melanoma cells.
PLoS One. 2010 Jul 14;5(7):e11574. doi: 10.1371/journal.pone.0011574.
8
miR-380-3p regulates melanogenesis by targeting SOX6 in melanocytes from alpacas (Vicugna pacos).
BMC Genomics. 2019 Dec 10;20(1):962. doi: 10.1186/s12864-019-6343-4.
10
MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines.
Cancer Res. 2008 Mar 1;68(5):1362-8. doi: 10.1158/0008-5472.CAN-07-2912.

引用本文的文献

1
A New Approach to Melanoma Treatment: microRNAs.
Curr Top Med Chem. 2024;24(16):1362-1376. doi: 10.2174/0115680266291290240417081544.
2
IGF2BP1 regulates the cargo of extracellular vesicles and promotes neuroblastoma metastasis.
Oncogene. 2023 May;42(19):1558-1571. doi: 10.1038/s41388-023-02671-0. Epub 2023 Mar 27.
3
Role of miRNA in Melanoma Development and Progression.
Int J Mol Sci. 2022 Dec 22;24(1):201. doi: 10.3390/ijms24010201.
6
IGF2BP1, a New Target to Overcome Drug Resistance in Melanoma?
Front Pharmacol. 2022 Jul 22;13:947363. doi: 10.3389/fphar.2022.947363. eCollection 2022.
7
The regulatory impact of RNA-binding proteins on microRNA targeting.
Nat Commun. 2021 Aug 20;12(1):5057. doi: 10.1038/s41467-021-25078-5.
8
microRNAs in the Regulation of Melanogenesis.
Int J Mol Sci. 2021 Jun 5;22(11):6104. doi: 10.3390/ijms22116104.
9
IGF2BP1, a Conserved Regulator of RNA Turnover in Cancer.
Front Mol Biosci. 2021 Mar 22;8:632219. doi: 10.3389/fmolb.2021.632219. eCollection 2021.

本文引用的文献

1
MicroRNA-340 as a modulator of RAS-RAF-MAPK signaling in melanoma.
Arch Biochem Biophys. 2014 Dec 1;563:118-24. doi: 10.1016/j.abb.2014.07.012. Epub 2014 Jul 17.
3
Inhibition of coding region determinant binding protein sensitizes melanoma cells to chemotherapeutic agents.
Pigment Cell Melanoma Res. 2012 Jan;25(1):83-7. doi: 10.1111/j.1755-148X.2011.00921.x. Epub 2011 Oct 28.
4
Wnt signaling stimulates transcriptional outcome of the Hedgehog pathway by stabilizing GLI1 mRNA.
Cancer Res. 2009 Nov 15;69(22):8572-8. doi: 10.1158/0008-5472.CAN-09-1500. Epub 2009 Nov 3.
7
CRD-BP protects the coding region of betaTrCP1 mRNA from miR-183-mediated degradation.
Mol Cell. 2009 Jul 31;35(2):240-6. doi: 10.1016/j.molcel.2009.06.007.
8
HuR recruits let-7/RISC to repress c-Myc expression.
Genes Dev. 2009 Aug 1;23(15):1743-8. doi: 10.1101/gad.1812509. Epub 2009 Jul 2.
10
Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor.
Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):1814-9. doi: 10.1073/pnas.0808263106. Epub 2009 Feb 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验